NGNE Competitors & Alternatives
Compare Neurogene Inc with similar stocks in the same industry
Biotechnology
NGNE
Main Stock$25.65
Tradestie Score
46
Market Cap
$256.54M
Analyst Upside
+213.6%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CTMX
CytomX Therapeutics, Inc.
|
$2.56
|
$552.46M | - | 46 | Compare |
|
VSTM
Verastem, Inc.
|
$7.70
|
$541.60M | - | 54 | Compare |
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$10.90
|
$540.97M | - | 47 | Compare |
|
MPLT
MPLT
|
$9.82
|
$535.19M | - | 47 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$9.99
|
$529.35M | 10.9 | 47 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$77.97
|
$522.78M | - | 57 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$1.82
|
$512.39M | - | 65 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$47.15
|
$505.12M | 2.9 | 57 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$96.99
|
$492.21M | - | 53 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$40.17
|
$474.20M | 28.2 | 46 | Compare |
More NGNE Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry